Herbal medicines: challenges in the modern world. Part 4. Canada and United States

Expert Review of Clinical Pharmacology

Volumn 9, Issue 12, 2016, Pages 1597-1609

  Job, Kathleen M ^a   Kiang, Tony K L ^b,c   Constance, Jonathan E ^a,d   Sherwin, Catherine M T ^a,d   Enioutina, Elena Yu ^a  

^a UNIVERSITY OF UTAH SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF BRITISH COLUMBIA   (Canada)

^c VANCOUVER GENERAL HOSPITAL   (Canada)

^d UNIVERSITY OF UTAH   (United States)

Author keywords

Canada; dietary supplements; Herbal medicines; legislation; natural health products; regulations; United States

Indexed keywords

HERBACEOUS AGENT; PLANT MEDICINAL PRODUCT;

CANADA; DIETARY SUPPLEMENT; DRUG EFFICACY; DRUG RESEARCH; DRUG SAFETY; HERBAL MEDICINE; HUMAN; NONHUMAN; REVIEW; UNITED STATES; DRUG LEGISLATION; MEDICINAL PLANT; PHYTOTHERAPY;

CANADA; HUMANS; LEGISLATION, DRUG; PHYTOTHERAPY; PLANT PREPARATIONS; PLANTS, MEDICINAL; UNITED STATES;

EID: 84997051968     PISSN: 17512433     EISSN: 17512441     Source Type: Journal    
DOI: 10.1080/17512433.2016.1238762     Document Type: Review

References (103)

1. Legends of America. Native American and other ancient remedies [Internet]. [cited 2016 May25]. Available from:http://www.legendsofamerica.com/na-remedy.html
2. Bent S., Herbal medicine in the United States:review of efficacy, safety, and regulation. J Gen Intern Med. 2008;23:854–859.
3. Bailey RL, Gahche JJ, Miller PE, et al. Why US adults use dietary supplements. JAMA Intern Med. 2013;173(5):355–361.
4. Ipsos Reid. Natural Health Product Tracking Survey–2010. Final report. Prepared for health Canada [Internet]. [cited 2016 May25]. Available from:http://epe.lac-bac.gc.ca/100/200/301/pwgsc-tpsgc/por-ef/health/2011/135-09/report.pdf•• The most recent survey conducted by the Canadian government describing trends and attitudes of Canadians toward natural health products.
5. Health Canada, the Natural and Non-prescription Health Products Directorate (NNHPD). Licensing Requirements [Internet]. [cited 2016 May25]. Available from:http://www.hc-sc.gc.ca/dhp-mps/prodnatur/about-apropos/index-eng.php - a2
6. Health Canada, the Natural and Non-prescription Health Products Directorate (NNHPD). About natural health product regulation in Canada [Internet]. [cited 2016 May25]. Available from:http://www.hc-sc.gc.ca/dhp-mps/prodnatur/about-apropos/index-eng.php
7. Dietary Supplement Health and Education Act of 1994. Public Law 103-417 [Internet]. [cited 2016 Jun2]. Available from:http://www.fda.gov/RegulatoryInformation/Legislation/SignificantAmendmentstotheFDCAct/ucm148003.htm•• The most comprehensive US legislative act pertaining to dietary supplements.
8. Natural and Non-prescription Health Products Directorate. What are natural health products? [Internet]. [cited 2016 May25]. Available from:http://www.hc-sc.gc.ca/dhp-mps/prodnatur/index-eng.php
9. Olatunde S, Boon H, Hirschkorn K, et al. Roles and responsibilities of pharmacists with respect to natural health products:key informant interviews. Res Social Admin Pharm:RSAP. 2010;6(1):63–69.
10. Byrne A, Boon H, Austin Z, et al. Core competencies in natural health products for Canadian pharmacy students. Am J Pharm Educ. 2010;74(3):45.
11. Health Canada. Natural health products–the evolution of regulations [Internet]. [cited 2016 May25]. Available from:http://www.hc-sc.gc.ca/dhp-mps/prodnatur/about-apropos/nhp-evolution-psn-eng.php
12. Health Canada, the Natural and Non-prescription Health Products Directorate (NNHPD). Search licensed natural health products [Internet]. [cited 2016 May25]. Available from:http://webprod5.hc-sc.gc.ca/lnhpd-bdpsnh/start-debuter.do?search-recherche-type=simple&lang=eng
13. Health Canada, the Natural and Non-prescription Health Products Directorate (NNHPD). Licensed Natural Health Product Database (LNHPD) data extract [Internet]. [cited 2016 May25]. Available from:http://www.hc-sc.gc.ca/dhp-mps/prodnatur/applications/licen-prod/lnhpd-bdpsnh_data_extract-eng.php
14. Walji R, Wiktorowicz M. Governance of natural health products regulation:an iterative process. Health Policy. 2013;111(1):86–94.
15. Bad Science Watch. About us [Internet]. [cited 2016 May25]. Available from:http://www.badsciencewatch.ca/about-us/
16. Health Canada, MedEffect Canada. Drugs and health products [Internet]. [cited 2016 May25]. Available from:http://www.hc-sc.gc.ca/dhp-mps/medeff/index-eng.php
17. Health Canada. Search the Canada vigilance adverse reaction online database [Internet]. [cited 2016 May25]. Available from:http://webprod3.hc-sc.gc.ca/arquery-rechercheei/index-eng.jsp
18. Shaw D, Graeme L, Pierre D, et al. Pharmacovigilance of herbal medicine. J Ethnopharmacol. 2012;140(3):513–518.
19. Debelle FD, Vanherweghem J-L, Nortier JL. Aristolochic acid nephropathy:a worldwide problem. Kidney Int. 2008;74(2):158–169.
20. Avigan MI, Mozersky RP, Seeff LB. Scientific and regulatory perspectives in herbal and dietary supplement associated hepatotoxicity in the United States. IJMS. 2016;17(3):331.
21. Newmaster SG, Grguric M, Shanmughanandhan D, et al. DNA barcoding detects contamination and substitution in North American herbal products. BMC Med. 2013;11:222.•• Widely-cited article reporting high incidence of product adulteration/substitution of health products already sold on the Canadian market.
22. Ventola CL. Current issues regarding Complementary and Alternative Medicine (CAM) in the United States:part 1:the widespread use of CAM and the need for better-informed health care professionals to provide patient counseling. P T. 2010;35(8):461–468.
23. Gurib-Fakim A. Medicinal plants:traditions of yesterday and drugs of tomorrow. Mol Aspects Med. 2006;27(1):1–93.
24. Adams JD, Garcia C. Women’s health among the Chumash. Evid Based Complement Alternat Med. 2006;3(1):125–131.
25. Adams JD, Garcia C. The advantages of traditional Chumash healing. Evid Based Complement Alternat Med. 2005;2(1):19–23.
26. Borchardt JK. Native American drug therapy:United States and Canada. Drug News Perspect. 2003;16(3):187–191.
27. Borchers AT, Keen CL, Stern JS, et al. Inflammation and Native American medicine:the role of botanicals. Am J Clin Nutr. 2000;72(2):339–347.
28. Yang Y, Li S. Dandelion extracts protect human skin fibroblasts from UVB damage and cellular senescence. Oxid Med Cell Longev. 2015;619560:2015.
29. Kantor M. The role of rigorous scientific evaluation in the use and practice of complementary and alternative medicine. J Am Coll Radiol. 2009;6(4):254–262.
30. Ventola CL. Current issues regarding Complementary and Alternative Medicine (CAM) in the United States:part 3:policies and practices regarding dietary supplements in health care facilities. P T. 2010;35(10):570–576.
31. National Institutes of Health, National Center for Complementary and Integrative Health. Complementary, alternative, or integrative health:What’s in a name? (2016) [Internet]. [cited 2016 May31]. Available from:https://nccih.nih.gov/health/integrative-health#cvsa
32. Young AL, Bass IS. The dietary supplement health and education act. Food Drug Law J. 1995;50(2):285–292.
33. Federal Food, Drug, and Cosmetic Act of 1994. 21 USC Chapter 9 Sections 321-399f [Internet]. [cited 2016 Jun2]. Available from:http://thomas.loc.gov/cgi-bin/bdquery/z?d101:HR03562:@@@D&summ2=3&%7CTOM:/bss/d101query.html
34. Clarke TC, Black LI, Stussman BJ, et al. Trends in the use of complementary health approaches among adults:United States, 2002–2012. Natl Health Stat Rep. 2015;79:1–16.• Results of most recent national US National Health Interview Survey describing trends in herbal and dietary supplements use in adults.
35. Greenblatt DJ, Peter RM, Pharmacology ACoC. American College of Clinical Pharmacology commentary on the Strategic Plan 2010–2014 Progress Report from the Office of Dietary Supplements, National Institutes of Health. J Clin Pharmacol. 2015;55(7):723–724.
36. Kemper KJ, Vohra S, Walls R, et al. American Academy of Pediatrics. The use of complementary and alternative medicine in pediatrics. Pediatrics. 2008;122(6):1374–1386.
37. Gahche J, Bailey R, Burt V, et al. Dietary supplement use among U.S. adults has increased since NHANES III (1988–1994). NCHS Data Brief. 2011;61:1–8.
38. Wu C-H, Wang -C-C, Kennedy J. The prevalence of herb and dietary supplement use among children and adolescents in the United States:results from the 2007 National Health Interview Survey. Complement Ther Med. 2013;21(4):358–363.
39. Peregoy JA, Clarke TC, Jones LI, et al. Regional variation in use of complementary health approaches by U.S. adults. NCHS Data Brief. 2014;146:1–8.
40. Black LI, Clarke TC, Barnes PM, et al. Use of complementary health approaches among children aged 4–17 years in the United States:National Health Interview Survey, 2007–2012. Natl Health Stat Rep. 2015;78:1–19.• Results of most recent national US National Health Interview Survey describing trends in herbal and dietary supplements use in children.
41. Kennedy J. Herb and supplement use in the US adult population. Clin Ther. 2005;27(11):1847–1858.
42. Stussman BJ, Black LI, Barnes PM, et al. Wellness-related use of common complementary health approaches among adults:United States, 2012. Natl Health Stat Rep. 2015;85:1–12.
43. Chedid V, Dhalla S, Clarke JO, et al. Herbal therapy is equivalent to rifaximin for the treatment of small intestinal bacterial overgrowth. Glob Adv Health Med. 2014;3(3):16–24.
44. Garcia-Cazarin ML, Wambogo EA, Regan KS, et al. Dietary supplement research portfolio at the NIH, 2009–2011. J Nutr. 2014;144(4):414–418.
45. Corey RL, Rakela J. Complementary and alternative medicine:risks and special considerations in pretransplant and posttransplant patients. Nutr Clin Pract. 2014;29(3):322–331.
46. Nahin RL, Barnes PM, Stussman BJ, et al. Costs of complementary and alternative medicine (CAM) and frequency of visits to CAM practitioners:United States, 2007. Natl Health Stat Rep. 2009;18:1–14.
47. Food and Drug Administration. Selected amendments to the FD&C Act [Internet]. [cited 2016 May31]. Available from:http://www.fda.gov/RegulatoryInformation/Legislation/SignificantAmendmentstotheFDCAct/default.htm
48. U.S. Pharmacopeial Convention. USP Milestones–A timeline [Internet]. [cited 2016 May31]. Available from:http://www.usp.org/about-usp/our-history/usp-milestones-timeline
49. Federal Trade Commission. Advertising guide for industry [Internet]. 2001. [cited 2016 Jun1]. Available from:https://www.ftc.gov/tips-advice/business-center/guidance/dietary-supplements-advertising-guide-industry
50. U.S. Pharmacopeial Convention. About USP [Internet]. [cited 2016 May31]. Available from:http://www.usp.org/about-usp
51. U.S. Pharmacopeial Convention. Legal recognition of USP standards [Internet]. [cited 2016 May31]. Available from:http://www.usp.org/about-usp/legal-recognition.
52. U.S. Pharmacopeial Convention Herbal Medicine Compendium. About the herbal medicines compendium [Internet]. [cited 2016 May31]. Available from:https://hmc.usp.org/about/about-the-herbal-medicines-compendium
53. U.S. Pharmacopeial Convention. USP & Pharmaceutical manufacturers [Internet]. [cited 2016 May31]. Available from:http://www.usp.org/usp-manufacturers/pharmaceuticals
54. U.S. Pharmacopeial Convention. USP Verified dietary supplements [Internet]. [cited 2016 May31]. Available from:http://www.usp.org/usp-verification-services/usp-verified-dietary-supplements
55. Kemper KJ, Vohra S, Walls R. The use of complementary and alternative medicine in pediatrics. Pediatrics. 2008;122(6):1374–1386
56. Food and Drug Administration. Guidance for industry:interim procedures for qualified health claims in the labeling of conventional human food and human dietary supplements (July 2003) [Internet]. [cited 2016 May31]. Available from:http://www.fda.gov/Food/GuidanceRegulation/GuidanceDocumentsRegulatoryInformation/LabelingNutrition/ucm053832.htm.
57. Food and Drug Administration. Guidance for industry:questions and answers regarding adverse event reporting and recordkeeping for dietary supplements as required by the dietary supplement and nonprescription drug consumer protection act; October 2007 (Revised June 2009 and September 2013) [Internet]. [cited 2016 May31]. Available from:http://www.fda.gov/food/guidanceregulation/guidancedocumentsregulatoryinformation/ucm171383.htm
58. Food and Drug Administration. Guidance for industry:current good manufacturing practice in manufacturing, packaging, labeling, or holding operations for dietary supplements; small entity compliance guide (December 2010) [Internet]. [cited 2016 May31]. Available from:http://www.fda.gov/food/guidanceregulation/guidancedocumentsregulatoryinformation/ucm238182.htm
59. Vitamin-Mineral Amendment of 1976. Public Law 94-278 [Internet]. [cited 2016 Jun2]. Available from:https://history.nih.gov/research/downloads/PL94-278.pdf
60. The Nutrition Labeling and Education Act of 1990. Public Law 101-535 [Internet]. [cited 2016 Jun2]. Available from:http://thomas.loc.gov/cgi-bin/bdquery/z?d101:HR03562:@@@D&summ2=3&%7CTOM:/bss/d101query.html
61. Food and Drug Administration. Dietary supplements [updated April4, 2016; cited 2016 Jul 14]. Available from:http://www.fda.gov/Food/DietarySupplements/default.htm
62. Wallace TC. Twenty years of the dietary supplement health and education act–how should dietary supplements be regulated? J Nutr. 2015;145(8):1683–1686.
63. Pawar RS, Grundel E. Overview of regulation of dietary supplements in the USA and issues of adulteration with phenethylamines (PEAs). Drug Test Anal. 2016. doi:10.1002/dta.1980. [Epub ahead of print]
64. Abdel-Rahman A, Anyangwe N, Carlacci L, et al. The safety and regulation of natural products used as foods and food ingredients. Toxicol Sci. 2011;123(2):333–348.
65. United States Congress. 65 FR 1000 (January 2000) [Internet]. [cited 2016 Jun1]. Available from:http://www.cfsan.fda.gov/~lrd/fr000106.html
66. Japsen B. Cost-conscious providers take to holistic medicine. Mod Healthc. 1995;25(34):138, 140, 142.
67. Orrin Hatch United States Senator for Utah. Hatch Marks 20th Anniversary of the Dietary Supplement Health and Education Act (DSHEA)-recognizes Utah’s $7 Billion nutritional products industry. [updated 2014 Oct27; cited 2016 May 31]. Available from:http://www.hatch.senate.gov/public/index.cfm/2014/10/hatch-marks-20th-anniversary-of-the-dietary-supplement-health-and-education-act-dshea
68. Food and Drug Administration H. Mitigation strategies to protect food against intentional adulteration. Final rule. Fed Regist. 2016;81(103):34165–34223.
69. Frankos VH, Street DA, O’Neill RK. FDA regulation of dietary supplements and requirements regarding adverse event reporting. Clin Pharmacol Ther. 2010;87(2):239–244.
70. Food and Drug Administration H. Administrative detention of food for human or animal consumption under the Public Health Security and Bioterrorism Preparedness and Response Act of 2002. Final rule. Fed Regist. 2004;69(108):31659–31705.
71. Dunn BK, Richmond ES, Minasian LM, et al. A nutrient approach to prostate cancer prevention:the Selenium and Vitamin E Cancer Prevention Trial (SELECT). Nutr Cancer. 2010;62(7):896–918.
72. Pittler MH, Schmidt K, Ernst E. Adverse events of herbal food supplements for body weight reduction:systematic review. Obes Rev. 2005;6(2):93–111.
73. Food and Drug Administration. Ephedrine Alkaloid-Containing Dietary Supplements:statement of Mark B. McClellan, M.D., Ph.D. Commissioner Food and Drug Administration before the Subcommittees on Commerce, Trade, and Consumer Protection and Oversight and Investigations House Committee on Energy and Commerce [updated 2003 Jul 24; cited 2016 May31]. Available from:http://www.fda.gov/newsevents/testimony/ucm115044.htm
74. Food and Drug Administration. FDA Issues regulation prohibiting sale of dietary supplements containing ephedrine alkaloids and reiterates its advice that consumers stop using these products [updated 2004 Feb 6; cited 2016 May31]. Available from:http://www.fda.gov/NewsEvents/Newsroom/PressAnnouncements/2004/ucm108242.htm
75. Kapoor A, Sharfstein JM. Breaking the gridlock:regulation of dietary supplements in the United States. Drug Test Anal. 2016;8(3–4):424–430.
76. Cohen PA, Bloszies C, Yee C, et al. An amphetamine isomer whose efficacy and safety in humans has never been studied, β-methylphenylethylamine (BMPEA), is found in multiple dietary supplements. Drug Test Anal. 2016;8(3–4):328–333.
77. Food and Drug Administration. Food. BMPEA in dietary supplements [updated 2015 Apr 27; cited 2016 May31]. Available from:http://www.fda.gov/Food/DietarySupplements/ProductsIngredients/ucm443790.htm
78. Vaclavik L, Krynitsky AJ, Rader JI. Mass spectrometric analysis of pharmaceutical adulterants in products labeled as botanical dietary supplements or herbal remedies:a review. Anal Bioanal Chem. 2014;406(27):6767–6790.
79. Vaclavik L, Krynitsky AJ, Rader JI. Targeted analysis of multiple pharmaceuticals, plant toxins and other secondary metabolites in herbal dietary supplements by ultra-high performance liquid chromatography-quadrupole-orbital ion trap mass spectrometry. Anal Chim Acta. 2014;810:45–60.
80. Vaclavik L, Krynitsky AJ, Rader JI. Quantification of aristolochic acids I and II in herbal dietary supplements by ultra-high-performance liquid chromatography-multistage fragmentation mass spectrometry. Food Addit Contam Part A Chem Anal Control Expo Risk Assess. 2014;31(5):784–791.
81. Vaclavik L, Vaclavikova M, Begley TH, et al. Determination of multiple mycotoxins in dietary supplements containing green coffee bean extracts using ultrahigh-performance liquid chromatography-tandem mass spectrometry (UHPLC-MS/MS). J Agric Food Chem. 2013;61(20):4822–4830.
82. Geller AI, Shehab N, Weidle NJ, et al. Emergency department visits for adverse events related to dietary supplements. N Engl J Med. 2015;373(16):1531–1540.
83. National Institutes of Health, National Center for Complementary and Integrative Health. Credentialing, licensing, and education [Internet]. [updated 2015 Mar 25; cited 2016 May31]. Available from:https://nccih.nih.gov/health/decisions/credentialing.htm#difference
84. Gardiner P, Sadikova E, Filippelli AC, et al. Medical reconciliation of dietary supplements:don’t ask, don’t tell. Patient Educ Couns. 2015;98(4):512–517.
85. Karpa KD, Boehmer S. Examining utilization of a natural medicine web-based tool among non-primary care physicians, academic faculty, and nurses at one institution. Ann Pharmacother. 2012;46(4):513–520.
86. U.S. Pharmacopeial Convention. USP-NF [Internet]. [cited 2016 Jun2]. Available from:http://www.usp.org/store/products-services/usp-nf
87. Offit PA, Erush S. Skip the supplements. The New York Times [Internet]. 2013 Dec 14 [cited 2016 May31]. Available from:http://www.nytimes.com/2013/12/15/opinion/sunday/skip-the-supplements.html?_r=0
88. Maggini V, Gallo E, Vannacci A, et al. e-Phytovigilance for misleading herbal information. Trends Pharmacol Sci. 2013;34(11):594–595.
89. National Institutes of Health, National Center for Complementary and Integrative Health. About NCCIH. [updated 2015 Nov 18; cited 2016 May31]. Available from:https://nccih.nih.gov/about
90. National Institutes of Health, National Center for Complementary and Integrative Health. NCCIH Timeline [updated 2015 Nov 25; cited 2016 May31]. Available from:https://nccih.nih.gov/about
91. National Institutes of Health, Office of Dietary Supplements. About. Mission, origin, and mandate [Internet]. [cited 2016 May31]. Available from:https://ods.od.nih.gov/About/MissionOriginMandate.aspx
92. White House Commission on Complementary and Alternative Medicine Policy. Final report (March 2002) [Internet]. [cited 2016 May31]. Available from:http://www.whccamp.hhs.gov/
93. National Institutes of Health. Dietary supplement ingredient database. 2001. [updated 2015 Mar20; cited 2016 Jul 14]. Available from:http://dsid.usda.nih.gov/
94. Academic Consortium for Integrative Medicine & Health. Mission [Internet]. 2016. [cited 2016 Jul14]. Available from:https://www.imconsortium.org/about/mission.cfm
95. Academic Consortium for Integrative Medicine & Health. Frequently asked questions [Internet]. 2016. [cited 2016 Jul14]. Available from:https://www.imconsortium.org/about/faq.cfm
96. Chow G, Liou KT, Heffron RC. Making whole:applying the principles of integrative medicine to medical education. R I Med J (2013). 2016;99(3):16–19.
97. Eisenberg DM, Kaptchuk TJ, Post DE, et al. Establishing an integrative medicine program within an academic health center:essential considerations. Acad Med. 2016;91(9):1223–1230.
98. Gagnier J, Boon H, Rochon P, et al. Improving the quality of reporting of randomized controlled trials evaluating herbal interventions:implementing the CONSORT statement [corrected]. Explore (NY). 2006;2(2):143–149.
99. Jurgens T, Whelan AM, MacDonald M, et al. Development and evaluation of an instrument for the critical appraisal of randomized controlled trials of natural products. BMC Complement Altern Med. 2009;9:11.
100. Necyk C, Tsuyuki RT, Boon H, et al. Pharmacy study of natural health product adverse reactions (SONAR):a cross-sectional study using active surveillance in community pharmacies to detect adverse events associated with natural health products and assess causality. BMJ Open. 2014;4(3):e003431.
101. Vohra S, Cvijovic K, Boon H, et al. Study of natural health product adverse reactions (SONAR):active surveillance of adverse events following concurrent natural health product and prescription drug use in community pharmacies. PLoS ONE. 2012;7(9):e45196.
102. Jiao H-C, Ju J-Q, Li Y-L, et al. Efficacy of Chinese herbal medicine on health-related quality of life (SF-36) in hypertensive patients:a systematic review and meta-analysis of randomized controlled trials. Complement Ther Med. 2015;23(3):494–504.
103. Parveen I, Gafner S, Techen N, et al. DNA Barcoding for the identification of botanicals in herbal medicine and dietary supplements:strengths and limitations. Planta Med. 2016;82(14):1225–1235.